Marol 200mg modified-release tablets (Teva)
BNF presentation 040702040BNADAE within chapter Central Nervous System. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Chapter
Presentation code
040702040BNADAE
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
23,094
NHS spend (£)
£273,100.10
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 2,743 |
| February 2025 | 27 |
| December 2024 | 804 |
| November 2024 | 3,036 |
| October 2024 | 3,101 |
| September 2024 | 13 |
| August 2024 | 310 |
| July 2024 | 3,245 |
| May 2024 | 930 |
| July 2021 | 1,422 |
| June 2021 | 1,131 |
| December 2020 | 2,867 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 84 | No data available |
| Unknown pharmacy | 77 | No data available |
| Unknown pharmacy | 70 | No data available |
| Unknown pharmacy | 69 | No data available |
| Unknown pharmacy | 67 | No data available |
| Unknown pharmacy | 67 | No data available |
| Unknown pharmacy | 64 | No data available |
| Unknown pharmacy | 64 | No data available |
| Unknown pharmacy | 63 | No data available |
| Unknown pharmacy | 58 | No data available |